70.59
+0.59(+0.84%)
Currency In USD
| Previous Close | 70 |
| Open | 70.65 |
| Day High | 70.88 |
| Day Low | 68.15 |
| 52-Week High | 71.5 |
| 52-Week Low | 5.35 |
| Volume | 1.61M |
| Average Volume | 3.25M |
| Market Cap | 3.87B |
| PE | -18.1 |
| EPS | -3.9 |
| Moving Average 50 Days | 38.64 |
| Moving Average 200 Days | 20 |
| Change | 0.59 |
If you invested $1000 in uniQure N.V. (QURE) 10 years ago, it would be worth $3,981.39 as of October 30, 2025 at a share price of $70.59. Whereas If you bought $1000 worth of uniQure N.V. (QURE) shares 5 years ago, it would be worth $1,745.98 as of October 30, 2025 at a share price of $70.59.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
GlobeNewswire Inc.
Sep 29, 2025 8:05 PM GMT
LEXINGTON, Mass. and AMSTERDAM, Sept. 29, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the closing of its previously
uniQure Announces Pricing of Upsized $300 Million Public Offering
GlobeNewswire Inc.
Sep 26, 2025 3:38 AM GMT
LEXINGTON, Mass. and AMSTERDAM, Sept. 25, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its previously
uniQure Announces $200 Million Proposed Public Offering
GlobeNewswire Inc.
Sep 24, 2025 8:06 PM GMT
LEXINGTON, Mass. and AMSTERDAM, Sept. 24, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commenced a $200 m